[证券分析师 Table_Authors] 周啸宇 S0630519030001 zhouxiaoy@longone.com.cn 证券分析师 于卓楠 S0630524100001 yzn@longone.com.cn 证券分析师 王珏人 S0630523100001 wjr@longone.com.cn [table_stockTrend] -30% -20% -10% 0% 10% 19% 29% 24-03 24-05 24-07 24-09 24-11 25-01 25-03 申万行业指数:电力设备(0763) [相关研究 table_product] [Table_Reportdate] 2025年03月18日 标配 1.帝科股份（300842）： 业绩稳步发 展，高铜浆料有望量产——公司简评 报告 2.光伏产业链价格企稳回升，关注全 国海风项目建设进程——新能源电 力行业周报（ 2025/03/03- 2025/03/07） 3.抢装带动行业需求回暖，多地海风 项目建设持续推进——新能源电力 行业周报（2025/02/24-2025/02/28） [Table_NewTitle 抢装带动中下游量价 ...

[Table_Reportdate] 2025年03月18日 超配 [证券分析师 Table_Authors] [相关研究 table_product] 1.扩内需促消费，政策催化持续—— 食品饮料行业周报（ 2025/3/3- 2025/3/9） 2.底部反弹，预期回暖——食品饮料 行业周报（2024/2/24-2025/3/2） 3.酒企积极停货稳价，政策驱动内需 复 苏 — — 食 品 饮 料 行 业 周 报 （2024/2/17-2025/2/23） [Table_NewTitle 政策力度加码，板块情绪回暖 ] ——食品饮料行业周报（2025/3/10-2025/3/16） 姚星辰 S0630523010001 yxc@longone.com.cn 联系人 吴康辉 wkh@longone.com.cn -30% -20% -10% 0% 10% 20% 30% 2024-03 2024-05 2024-07 2024-09 2024-11 2025-01 2025-03 食品饮料(申万) 沪深300 [table_main] 投资要点： 行 业 研 究 品 饮 料 证券研究报告 HTTP://WWW ...

[晨会纪要 Table_NewTitle] 20250318 [Table_Reportdate] 2025年03月18日 [证券分析师： Table_Authors] 张季恺 S0630521110001 zjk@longone.com.cn 证券分析师： 刘思佳 S0630516080002 liusj@longone.com.cn 证券分析师： 王洋 S0630513040002 wangyang@longone.com.cn [table_main] 重点推荐 晨 会 纪 要 证券研究报告 HTTP://WWW.LONGONE.COM.CN 请务必仔细阅读正文后的所有说明和声明 [Table_Report] ➢ 1.开门红已现，关注后续政策落实——国内观察：2025年1-2月经济数据 ➢ 2.海外数据波动与国内资产的确定性——资产配置周报（2025/03/10-2025/03/14） ➢ 1.国新办召开新闻发布会，介绍提振消费有关情况 ➢ 2.美国2月零售销售低于预期 ➢ 3.经合组织因贸易紧张局势下调全球经济增长展望 | 1.1. 开门红已现，关注后续政策落实——国内观察：2025 1-2 ... ...

Investment Rating - The industry investment rating is "Overweight" indicating that the industry index is expected to outperform the CSI 300 index by 10% or more over the next six months [39]. Core Insights - The pharmaceutical and biotechnology sector saw an overall increase of 1.77% from March 9 to March 14, ranking 15th among 31 industries in the Shenwan index, outperforming the CSI 300 index by 0.18 percentage points [3][13]. - Year-to-date, the sector has risen by 3.99%, ranking 16th among 31 industries, and has outperformed the CSI 300 index by 2.17 percentage points [14]. - The current PE valuation for the pharmaceutical and biotechnology sector is 26.59 times, which is at a historically low level, with a valuation premium of 123% compared to the CSI 300 index [17]. Market Performance - The top three sub-sectors in terms of growth were pharmaceutical commerce (6.44%), traditional Chinese medicine II (2.63%), and biological products (1.63%) [3][13]. - A total of 353 stocks (74.47% of the sector) increased in value last week, with the top five performers being Jincheng Pharmaceutical (42.43%), Saili Medical (34.47%), Dongfang Ocean (25.00%), Laobaixing (22.47%), and Dajia Weikang (21.14%) [22]. Industry News - On March 13, the government of Hohhot announced policies to promote population aggregation and high-quality development, including free newborn screening and integration of medical and elderly care services [4][28]. - The "Consumption Promotion Special Action Plan" issued by the central government on March 16 aims to activate the healthcare industry through four main paths: expanding medical insurance, empowering technology, upgrading elderly services, and international openness [5][32]. Investment Recommendations - The report suggests focusing on investment opportunities in medical services, chain pharmacies, second-class vaccines, innovative drug chains, and medical equipment sectors [6][35]. - Recommended stocks include Huaxia Eye Hospital, Laobaixing, Kangtai Biological, Tebao Biological, and Nuotai Biological [36]. Summary of Policies - Hohhot's policies aim to lower childbirth costs and improve medical security, which is expected to stimulate maternal and infant health testing and consumption in the short term, benefiting the child health and elderly care industries in the long term [28][30]. - The "Consumption Promotion Special Action Plan" emphasizes the importance of intelligent medical devices, innovative drugs, community elderly care, internet medical services, and high-end specialized medical services [5][32].

[证券分析师： Table_Authors] 张季恺 S0630521110001 zjk@longone.com.cn 证券分析师： 刘思佳 S0630516080002 liusj@longone.com.cn 证券分析师： 王洋 S0630513040002 wangyang@longone.com.cn [Table_Reportdate] 2025年03月18日 [晨会纪要 Table_NewTitle] 20250318 [table_main] 重点推荐 财经要闻 晨 会 纪 要 证券研究报告 HTTP://WWW.LONGONE.COM.CN 请务必仔细阅读正文后的所有说明和声明 [Table_Report] ➢ 1.开门红已现，关注后续政策落实——国内观察：2025年1-2月经济数据 ➢ 2.海外数据波动与国内资产的确定性——资产配置周报（2025/03/10-2025/03/14） ➢ 1.国新办召开新闻发布会，介绍提振消费有关情况 ➢ 2.美国2月零售销售低于预期 ➢ 3.经合组织因贸易紧张局势下调全球经济增长展望 | 1.1. 开门红已现，关注后续政策落实——国内观察：2025 1-2 ...

跑输 [Table_Reportdate] 2025年03月17日 超配 行 业 周 报 [证券分析师 Table_Authors] 杜永宏 S0630522040001 dyh@longone.com.cn 证券分析师 伍可心 S0630522120001 wkx@longone.com.cn [table_stockTrend] [相关研究 table_product] 1.关注药品价格新趋势——医药生 物行业周报（2025/3/3-2025/3/9） 2.轻舟已过，耐心布局—医药生物行 业2025年度策略 3.收入端企稳，利润端可期——医药 生物行业2024年三季报业绩综述 [Table_NewTitle 关注医疗服务消费投资机会 ] ——医药生物行业周报（2025/3/9-2025/3/14） [table_main] 投资要点： ➢ 市场表现： 上周（3月9日-3月14日）医药生物板块整体上涨1.77%，在申万31个行业中排第15位, 跑赢沪深300指数0.18个百分点。年初至今，医药生物板块整体上涨3.99%，在申万31个 行业中排第16位，跑赢沪深300指数2.17个百分点。当前，医药生物板块P ...

1.券业并购重组预期升温，险企对外 开放再深化——非银金融行业周报 （20250224-20250302） 2.资本市场助力书写金融"五篇大文 章"，险资投资黄金试点启动——非 银 金 融 行 业 周 报 （ 20250203- 20250209） 3.落实长周期考核，助力培育耐心资 本——中长期资金系列研究（一） [Table_Reportdate] 2025年03月17日 超配 业 周 报 陶圣禹 S0630523100002 tsy@longone.com.cn 63% [table_stockTrend] -29% -14% 2% 17% 32% 48% 24-03 24-06 24-09 24-12 申万行业指数:非银金融(0749) 沪深300 [相关研究 table_product] [Table_NewTitle 湘财拟合并大智慧引导券业并购创新， ] 长端利率企稳改善险资再配置收益 ——非银金融行业周报（20250310-20250316） [table_main] 投资要点： 行 证券研究报告 HTTP://WWW.LONGONE.COM.CN 请务必仔细阅读正文后的所有说明和声明 行 业 ...

[Table_Reportdate] 2025年03月17日 超配 业 周 报 陶圣禹 S0630523100002 tsy@longone.com.cn 63% [table_stockTrend] -29% -14% 2% 17% 32% 48% 24-03 24-06 24-09 24-12 申万行业指数:非银金融(0749) 沪深300 [相关研究 table_product] 1.券业并购重组预期升温，险企对外 开放再深化——非银金融行业周报 （20250224-20250302） 2.资本市场助力书写金融"五篇大文 章"，险资投资黄金试点启动——非 银 金 融 行 业 周 报 （ 20250203- 20250209） 3.落实长周期考核，助力培育耐心资 本——中长期资金系列研究（一） [Table_NewTitle 湘财拟合并大智慧引导券业并购创新， ] 长端利率企稳改善险资再配置收益 ——非银金融行业周报（20250310-20250316） [table_main] 投资要点： 行 证券研究报告 HTTP://WWW.LONGONE.COM.CN 请务必仔细阅读正文后的所有说明和声明 行 业 ...

Economic Overview - In January-February 2025, the total retail sales of consumer goods increased by 4.0% year-on-year, up from 3.7% in the previous period[3] - Fixed asset investment (FAI) grew by 4.1% year-on-year, compared to 3.2% previously[3] - The industrial added value for large-scale industries rose by 5.9% year-on-year, slightly down from 6.2% in December 2024[3] Industrial Performance - The high-tech manufacturing sector showed significant growth, with added value increasing by 9.1%, accelerating by 1.2 percentage points from December 2024[3] - The equipment manufacturing sector outperformed the overall industrial growth, achieving a year-on-year increase of 10.6%[3] - Industrial production growth remained stable, with a slight decline of 0.3 percentage points from the previous month[3] Consumer Trends - The consumption recovery is still dependent on further policy implementation, with the service retail sector growing by 4.9% year-on-year, down 1.3 percentage points from 2024[3] - The automotive sector's sales lagged behind last year, while non-automotive retail sales grew by 4.8%[3] - The expansion of the "old-for-new" policy is showing effects, particularly in categories like communication equipment and jewelry, which saw notable increases[3] Investment Insights - High-tech industry investment rose by 9.7% year-on-year, significantly above the overall FAI growth rate[3] - Infrastructure investment maintained a high growth rate of 9.94%, while narrow infrastructure investment slightly declined to 5.6%[5] - Real estate sales for new homes fell by 5.1% year-on-year, indicating a need for new policy measures to stabilize the market[3] Risks and Outlook - Potential risks include slower-than-expected policy implementation and ongoing downward pressure in the real estate market[5] - The U.S. economic recession poses a risk to exports, necessitating a focus on expanding domestic demand as a key policy direction for the year[3]

[Table_Reportdate] 2025年03月17日 [开门红已现，关注后续政策落实 Table_NewTitle] ——国内观察：2025年1-2月经济数据 [证券分析师 Table_Authors] ➢ 事件：3月17日，国家统计局公布2025年1-2月经济数据。1-2月社零总额同比4.0%，前值 3.7%；固投同比4.1%，前值3.2%；规上工业增加值同比5.9%，前值6.2%。 ➢ 核心观点：1-2月经济数据整体偏积极。高技术产业是较大亮点，高技术制造业增加值及高 技术产业投资均明显高于整体水平。工业生产增速小幅回落但维持相对高位，装备制造表 现好于整体；社零及固投增速较去年12月均有所改善，"两新"政策的扩容加力效果开始 显现；地产销售新房要弱于二手房，仍需要新一轮的政策加力，投资端土拍溢价率回升是 积极的信号，未来需要关注专项债收储的进度及规模。全年来看，一方面美国存在衰退风 险，另一方面关税压力或逐步显现，二季度后出口或面临压力，扩大内需仍是全年的政策 主线，关注两会后政策的落实节奏。 ➢ 工业生产小幅回落但相对稳定，高技术及装备制造表现较好。1-2月规模以上工业增加值 同比5.9%，较 ...